The curative role of radiotherapy in the treatment of operable breast cancer

European Journal of Cancer

Volumn 38, Issue 15, 2002, Pages 1961-1974

  Kurtz, J ^a   Bartelink, H ^b   Cataliotti, L ^b   Cuzick, J ^c   Dunst, J ^b   Ewertz, M ^b   Fodor, J ^b   Fourquet, A ^b   Greco, M ^b   Hammer, J ^b   Jassem, J ^b   Kunkler, I ^d   Orecchia, R ^b   Ponti, A ^b   Romestaing, P ^b   Van Limbergen, E ^b   Yarnold, J ^e  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE   (Belgium)

^c Centre for Telecommunications Research   (United Kingdom)

^d Edinburgh Rugby   (United Kingdom)

^e Sutton Eye Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE;

AXILLARY LYMPH NODE; BRACHIAL PLEXUS; BREAST CANCER; BREAST DUCT; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL TRIAL; EDEMA; FIBROSIS; FROZEN SHOULDER; HUMAN; INTERMETHOD COMPARISON; LUNG DISEASE; LYMPH NODE; MASTECTOMY; NEUROPATHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION RESPONSE; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 84988306075     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00314-3     Document Type: Article

References (75)

1. Early Breast Cancer Trialists' Collaborative Group Effects of radiotherapy and surgery in early breast cancer - an overview of the randomized trials. N Engl J Med. 333:1995;1444-1455.
2. Early Breast Cancer Trialists' Collaborative Group Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 355:2000;1757-1770.
3. Cuzick J., Stewart H., Rutqvist L.et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 12:1994;447-453.
4. Overgaard M., Hansen P.S., Overgaard J.et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
5. Overgaard M., Jensen M.B., Overgaard J.et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 353:1999;1641-1648.
6. Rutgers E.J.T. for the EUSOMA Consensus Group. Quality control in the locoregional treatment of breast cancer. Eur J Cancer. 37:2001;447-453.
7. Whelan T.J., Julian J., Wright J., Jadad A.R., Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 18:2000;1220-1229.
8. EUSOMA Position Paper The requirements of a specialist breast unit. Eur J Cancer. 36:2000;2288-2293.
9. Harris JR, Morrow M. Local management of invasive breast cancer. In Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the Breast. Philadelphia. New York, Lippincott-Raven, 1996, 487-547.
10. Bentel G., Marks L.B., Hardenbergh P., Prosnitz L. Variability in the location of internal mammary vessels and glandular breast tissue in breast cancer patients undergoing routine CT-based treatment planning. Int J Radiat Oncol Biol Phys. 44:1999;1017-1025.
11. Hurkmans C.W., Borger J.H., Bos L.J.et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol. 55:2000;145-151.
12. International Commission on Radiation Units and Measurements Prescribing, Recording, and Reporting Photon Beam Therapy. ICRU Report 50. 1994;ICRU Publications, Bethesda, MD, USA.
13. Lievens Y., Poortmans P., Van den Bogaert W. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer. Radiother Oncol. 60:2001;257-265.
14. START Trial Management Group Standardisation of breast radiotherapy (START) trial. Clin Oncol. 11:1999;145-147.
15. Fisher B., Bryant J., Wolmark N.et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 16:1998;2672-2685.
16. Nixon A.J., Recht A., Neuberg D.et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys. 30:1994;17-21.
17. Bellon J.R., Come S.E., Gelman R.S.et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a randomized prospective study. Int J Radiat Oncol Biol Phys. 51:2001;S1. (Abstr. 4.).
18. Shapiro C.L., Hardenbergh P.H., Gelman R.et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol. 16:1998;3493-3501.
19. Lichter A.S., Fraas B.A., Yanke B. Treatment techniques in the conservative management of breast cancer. Semin Radiat Oncol. 2:1992;94-106.
20. Sauer R., Wallgren A., Kurtz J.M. Adjuvant radiotherapy after breast conserving surgery for breast cancer. Eur J Cancer. 36:2000;1073-1084.
21. Clark R.M., Whelan T., Levine M.et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst. 88:1996;1659-1664.
22. Forrest A.P., Stewart H.J., Everington D.et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet. 348:1996;708-713.
23. Fisher B., Anderson S., Redmond C.K.et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 333:1995;1456-1461.
24. Liljegren G., Holmberg L., Bergh J.et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 17:1999;2326-2333.
25. Veronesi U., Marubini E., Mariani L.et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 12:2001;997-1003.
26. Bornstein B.A., Cheng C.W., Rhodes L.M.et al. Can simulation measurements be used to predict the irradiated lung volume in the tangential fields in patients treated for breast cancer? Int J Radiat Oncol Biol Phys. 18:1990;181-187.
27. Whelan T.J., Levine M., Julian J., Kirkbride P., Skingley P. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Cancer. 88:2000;2260-2266.
28. Liljegren G., Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer. 33:1997;193-199.
29. Liljegren G., Holmberg L., Westman G. The cosmetic outcome in early breast cancer treated with sector resection with and without radiotherapy. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer. 29:1993;2083-2089.
30. Sacchini V., Luini A., Agresti R.et al. The influence of radiotherapy on cosmetic outcome after breast conservative surgery. Int J Radiat Oncol Biol Phys. 33:1995;59-61.
31. Moody A.M., Mayles W.P.M., Bliss J.M.et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol. 33:1994;106-112.
32. Fisher B., Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NASBP trials. World J Surg. 18:1994;63-69.
33. Fraass B.A., Roberson P.L., Lichter A.S. Dose to the contralateral breast due to primary breast irradiation. Int J Radiat Oncol Biol Phys. 11:1985;485-497.
34. Nixon A.J., Manola J., Gelman R.et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 16:1998;1374-1379.
35. Paszat L.F., Mackillop W.J., Groome P.A.et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 43:1999;755-762.
36. Zambetti M., Moliterni A., Materazzo C.et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol. 19:2001;37-43.
37. Gyenes G., Gagliardi G., Lax I.et al. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol. 15:1997;1348-1353.
38. Landau D., Adams E.J., Webb S., Ross G. Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol. 60:2001;247-255.
39. Canney P.A., Sanderson R., Deehan C., Wheldon T. Variation in the probability of cardiac complications with radiation technique in early breast cancer. Br J Radiol. 74:2001;262-265.
40. Hurkmans C.W., Borger J.H., van Giersbergen A.et al. Implementation of a forearm support to reduce the amount of irradiated lung and heart in radiation therapy of the breast. Radiother Oncol. 61:2001;193-196.
41. Bartelink H., Horiot J.C., Poortmans P.M.et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 345:2001;1378-1387.
42. Romestaing P., Lehingue Y., Carrie C.et al. Role of a 10 Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 15:1997;963-968.
43. Vrieling C., Collette L., Fourquet A.et al. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC <> Trial. Int J Radiat Oncol Biol Phys. 45:1999;677-685.
44. Van Limbergen E., Briot E., Drijkoningen M. The skin-source measuring bridge. A method to avoid radiation teleangiectasia in the skin after interstitial implants for breast cancer. Int J Radiat Oncol Biol Phys. 18:1990;1239-1244.
45. Borger J.H., Kemperman H., Smitt H.S.et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys. 30:1994;1073-1081.
46. Hammer J., Mazeron J.J., Van Limbergen E. Breast boost - why, how, when? Strahlenther Onkol. 175:1999;478-483.
47. Julien J.P., Bijker N., Fentiman I.S.et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet. 355:2000;528-533.
48. Fisher B., Dignam J., Wolmark N.et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 16:1998;441-452.
49. Silverstein M.J., Lagios M.D., Groshen S.et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 340:1999;1455-1461.
50. Early Breast Cancer Trialists' Collaborative Group Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 352:1998;930-942.
51. Early Breast Cancer Trialists' Collaborative Group Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 351:1998;1451-1467.
52. Paszat L.F., Mackillop W.J., Groome P.A.et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End-Results cancer registries. J Clin Oncol. 16:1998;2638-2640.
53. Gyenes G., Rutqvist L.E., Liedberg A., Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol. 48:1998;185-190.
54. Gagliardi G., Lax I., Rutqvist L.E. Partial irradiation of the heart. Semin Radiat Oncol. 11:2001;224-233.
55. Hojris I., Overgaard M., Christensen J.J., Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Lancet. 354:1999;1425-1430.
56. Recht A., Edge S.B., Solin L.J.et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol. 19:2001;1539-1569.
57. Recht A., Gray R., Davidson N.et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 17:1999;1689-1700.
58. Chetty U., Jack W., Prescott R.J.et al. Management of the axilla in operable breast cancer treated by breast conservation: a randomised clinical trial. Br J Surg. 87:2000;163-169.
59. Freedman G.M., Fowble B., Hoffman J.et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys. 46:2000;805-814.
60. Dunscombe P., Samant R., Roberts G. A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in premenopausal node-positive breast cancer patients. Int J Radiat Oncol Biol Phys. 48:2000;977-982.
61. Katz A., Strom E.A., Buchholz T.A., Thames H.D.et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 18:2000;2817-2827.
62. O'Rourke S., Galea M.H., Morgan D.et al. Local recurrence after simple mastectomy. Br J Surg. 81:1994;386-389.
63. Katz A., Strom E.A., Buchholtz T.A.et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 50:2001;735-742.
64. Kuske R.R., Schuster R., Klein E.et al. Radiotherapy and breast reconstruction: Clinical results and dosimetry. Int J Radiat Oncol Biol Phys. 21:1991;339-346.
65. Krueger E.A., Wilkins E.G., Strawderman M.et al. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys. 49:2001;713-721.
66. Williams J.K., Bostwick J., Bried J.T.et al. TRAM flap breast reconstruction after radiation treatment. Ann Surg. 221:1995;756-766.
67. Tran N.V., Chang D.W., Gupta Aet al. Comparison of immediate and delayed free TRAM flap reconstruction in patients receiving postmastectomy radiotherapy. Plast Reconst Surg. 108:2001;78-82.
68. Zimmerman R.P., Mark R.J., Kim A.L.et al. Radiation tolerance of transverse rectus abdominus myocutaneous-free flaps used in immediate breast reconstruction. Am J Clin Oncol. 281:1998;381-385.
69. Magee B., Swindell R., Harris M., Banerjee S.S. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol. 39:1996;223-227.
70. Faverly D.R.G., Hendriks J.H.C.L., Holland R. Breast carcinomas of limited extent. Frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 91:2001;647-659.
71. Vicini F.A., Baglan K.L., Kestin L.L.et al. Accelerated treatment of breast cancer. J Clin Oncol. 19:2001;1993-2001.
72. Veronesi U., Orecchia R., Luini A.et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 37:2001;2178-2183.
73. Schnitt S.J., Hayman J., Gelman R.et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer. 77:1996;1094-1100.
74. Fryles A, McCready D, Manchul L, et al. Preliminary results of a randomized study of tamoxifen +/-breast radiation in T1/2N0 disease in women over 50 years of age. Proc Am Soc Clin Oncol 2001 (abstr. 92).
75. Hughes KS, Schnaper L, Berry D, Cirrincione C, et al. Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage I, estrogen receptor positive (ER+) breast carcinoma. Proc Am Soc Clin Oncol 2001 (abstr).